Contribution of Nasal High Flow in Pneumology Assessed in Acid-Free Hypercapnic Acute Respiratory Failure

NARecruitingINTERVENTIONAL
Enrollment

126

Participants

Timeline

Start Date

February 27, 2024

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions
Respiratory Insufficiency
Interventions
DEVICE

AIRVO3 TM

A device that provides high flows of heated and humidified respiratory gases to patient who breath spontaneously. Patients will be treated with the device up to 15 days or until the occurrence of respiratory acidosis defined by pH\<7.35, whichever come first.

OTHER

Standard therapy

Standard therapy depends on the acute respiratory failure etiology. Treatments will be administered at the investigator's discretion in accordance with the standard of care.

Trial Locations (3)

83100

RECRUITING

Centre Hospitalier Intercommunal de Toulon- La Seyne sur Mer - Hôpital Sainte Musse, Toulon

98000

RECRUITING

Centre Hospitalier Princesse Grace, Monaco

06400

TERMINATED

Centre Hospitalier de Cannes, Cannes

All Listed Sponsors
lead

Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer

OTHER